Course Description/Overview

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.

Target Audience

This activity has been designed to meet the educational needs of primary care providers, including internists, family physicians, nurse practitioners, and physician assistants, involved in the ongoing management of patients with severe asthma.

Educational Objectives

Upon completion of these activities, participants should be better able to do the following:

  1. Diagnose cases of severe asthma based on ongoing evaluations of symptom control, medical history, and treatment responses
  2. Personalize multidisciplinary management plans for patients with severe asthma to reflect exacerbation risks, treatment responses, patient preferences, and shared decision-making

Faculty

Jonathan Corren, MD
Associate Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Section of Clinical Immunology and Allergy
Los Angeles, California

Barbara P. Yawn, MD, MSc, FAAFP
Adjunct Professor, Department of Family and Community Health
University of Minnesota
Minneapolis, Minnesota

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose any real or apparent conflicts of interest relating to the topics of this educational activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Jonathan Corren, MD: Speakers Bureau: AstraZeneca; Genentech, Inc.; Teva Pharmaceutical Industries Ltd.; Consultant/Advisor: AstraZeneca; Regeneron Pharmaceuticals, Inc.; sanofi-aventis U.S. LLC; Research Grant: AstraZeneca; Genentech, Inc.; Regeneron Pharmaceuticals, Inc.; sanofi-aventis U.S. LLC; Stallergenes Greer plc

Barbara P. Yawn, MD, MSc, FAAFP: Consultant/Advisor: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation

Non-faculty

Rose O’Connor, PhD, CHCP;  Sandy Breslow; Alison Kemp; and Bernard M. Abrams, MD, hereby state that neither they nor their spouses/life partners have had any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 

Financial Support

These activities have been supported by an independent educational grant from AstraZeneca.

CME Credit (Physicians)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and Integritas Communications. The Elsevier Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Integritas Communications, and AstraZeneca do not recommend the use of any agent outside of the labeled indications. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of each activity
  2. Complete the Pre-Activity Questions.
  3. Read or review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. A physician who achieves a grade of 70% or better on the Postactivity Test and who completes the Evaluation will receive a CME Certificate.
  6. Any other participant who achieves a grade of 70% or better on the Postactivity Test and who completes the Evaluation will receive a Certificate of Participation.
Begin Activity